New study finds that CBD can be effective in treating heroin addiction

By | May 22nd, 2019|Categories: Addiction, Anxiety, Cannabis, CBD, Epidiolex, GW Pharmaceutical, Mental Health, News, Research, USA|

American researchers have found more evidence that CBD can be used to help treat addiction to heroin Addicts given CBD were 2-3 times less likely to exhibit cravings for heroin than those given placebos Anxiety and stress levels were also significantly lower in those who were given CBD A new study has found [...]

NHS to launch review as British families forced to pay £40k for medical cannabis prescriptions

By | May 14th, 2019|Categories: Cannabis, Cannabis Oil, CBD, Children, Doctors, Dravet Syndrome, Epidiolex, Epilepsy, GW Pharma, GW Pharmaceutical, Home Grow, Legalisation, News|

Government drug task force APPG has put 22 families to speak to the NHS Patients must pay up to £40,000 per year to get a private prescription for medical cannabis No prescriptions have been given on the NHS for medical cannabis Twenty-two UK families who have been forced to pay £10,000s for private [...]

MPs told that Pharmaceutical Industry should be funding trials for medical cannabis, not the public sector

By | March 22nd, 2019|Categories: Cannabis, Cannabis Oil, Cannabis Prohibiton, CBD, Children, Doctors, Epidiolex, Epilepsy, GW Pharmaceutical, Legalisation, News, NHS, Research, THC, UK|

The UK Government currently provides the funding for clinical trials on medical cannabis England’s chief medical officer told MPs that the private sector should be paying their fair share Only 80 patients have been prescribed CBD on the NHS so far Only patients with a private prescription have been able to acquire medical [...]

MPs told that Pharmaceutical Industry should be funding medical cannabis trials, not the public sector

By | March 22nd, 2019|Categories: Cannabis, Cannabis Oil, Cannabis Prohibiton, CBD, Children, Doctors, Endocannabinoids, Epidiolex, GW Pharmaceutical, Legalisation, News, NHS, Opiates, Opioids, Pharmaceuticals, Research, Seizures, THC, UK|

The UK Government currently provides the funding for clinical trials on medical cannabis England’s chief medical officer told MPs that the private sector should be paying their fair share Only 80 patients have been prescribed CBD on the NHS so far Only patients with a private prescription have been able to acquire medical [...]

Study finds that long-term cannabis users are physically healthier than non-cannabis users

By | March 13th, 2019|Categories: GW Pharmaceutical, Inflammation, Legalisation, New Zealand, News, Obesity, Research, Teenagers, THC, USA, Weight Loss|

1,037 New Zealanders were studied over 38 year period Researchers found cannabis users have superior metabolic health than non-cannabis users The only negative effect cannabis has on the physical body is in the teeth A study has found evidence that cannabis doesn’t harm the human body, even with long-term use. Researchers at Arizona [...]

House of Lords criticises British Government for failing “desperate” medical cannabis patients

By | March 5th, 2019|Categories: Cancer, Cannabis, Cannabis Oil, Cannabis Prohibiton, CBD, Doctors, Dravet Syndrome, Endocannabinoids, Epidiolex, GW Pharmaceutical, House of Lords, Legalisation, Mental Health, Mothers, Multiple Sclerosis, News, NHS, Opioids, Pain, Patient Stories, Police, Psychosis, Research, Seizures, Smoking, THC, UK|

Lords slammed the British Government for failing medical cannabis patients  Only four patients have received a prescription for medical cannabis  Some patients are forced to travel abroad for their prescriptions One Lord claimed “majority of terrorists” in the UK are heavy users of cannabis Members of the House of Lords slammed the British Government [...]

Multinational Cannabis firm to open first medical cannabis clinic in the Manchester, UK

By | March 2nd, 2019|Categories: Cannabis, Cannabis Prohibiton, Children, Doctors, Epidiolex, GW Pharmaceutical, Inflammation, Legalisation, Mental Health, Mothers, MS, Multiple Sclerosis, News, NHS, UK, UPA|

Clinics providing cannabinoid-based medications will open in the UK later this year They will be the first in the UK, expanding options for patients desperate to get medical cannabis prescriptions Only 4 patients in the UK have been granted private prescriptions in the UK, costing tens of thousands per yer Professor Mike Barnes [...]

Uruguayan cannabis companies to begin exporting to other countries

By | February 8th, 2019|Categories: Cannabis, GW Pharmaceutical, Legalisation, News, THC, Uruguay|

Uruguay legalised cannabis in December 2013 Citizens can legally purchase, use and grow cannabis at home The country now hopes to become a world leader in medical cannabis exports Uruguay rewrote history in 2013 when the country became the first to fully legalise cannabis for recreational use for all citizens. Citizens and legal [...]

Scottish Child One of Ten Wins Victory to be prescribed Medical Cannabis Oil

By | January 17th, 2019|Categories: Cannabis, Cannabis Oil, CBD, Children, Dravet Syndrome, Epidiolex, GW Pharmaceutical, Mothers, News, Parent, Patient Stories, THC, UK|

Scottish child, Cole Thomson, is set to be one of 10 children to receive a prescription for Epidolex Cole suffers drug-resistant epilepsy Up to 7000 children in Scotland have been diagnosed with epilepsy The East Kilbride News revealed yesterday that Cole Thomson, 6, will be one of only 10 children in Scotland to [...]

Could South Korea become the first Asian country to legalise medical cannabis?

By | November 27th, 2018|Categories: Cancer, Cannabis, Cannabis Oil, Cannabis Prohibiton, Children, Dravet Syndrome, Epidiolex, Epilepsy, GW Pharmaceutical, Legalisation, News, South Korea, Uncategorised|

The Act on the Management of Narcotic Drugs has passed the preliminary stage in South Korea’s National Assembly The Act will permit citizens to be prescribed medical cannabis for epilepsy, cancer and HIV/AIDs Foreign citizens will now be allowed to import approved cannabinoid-based products if there are no alternatives. Cultivation and importation of [...]